Last reviewed · How we verify
NCT04721392
Mental Fatigue and Industrial Work Performance
NA trial testing Mental fatigue (Stroop task) in Healthy in 12 participants. Completed in 14 August 2021.
14 August 2021
Quick facts
| Lead sponsor | Vrije Universiteit Brussel |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 12 |
| Start date | 8 March 2021 |
| Primary completion | 14 August 2021 |
| Estimated completion | 14 August 2021 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Mental fatigue (Stroop task)
- Control (documentary)
Conditions studied
- Healthy — all drugs for Healthy →
- Mental Fatigue — all drugs for Mental Fatigue →
- Industrial Work — all drugs for Industrial Work →
- Robotics — all drugs for Robotics →
Sponsor
Vrije Universiteit Brussel — full company profile →
Who can join
Adults 18 to 64, any sex, with Healthy or Mental Fatigue. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate the effect of mental fatigue on industrial work performance, biomechanical determinants, (electro-)(psycho-) physiological measures and physical ergonomics. Additionally, the current project wants to evaluate whether or not the Laevo exoskeleton influences the aforementioned parameters when mental fatigue is acutely induced.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04721392
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Vrije Universiteit Brussel trials
Trials by the same sponsor.
- NCT07460778 — Development of Serious Games for Rehabilitation: a Delphi Study · NA · recruiting
- NCT07359521 — Implementation and Evaluation of a Complex Intervention to Reduce Avoidable Transitions Between Nursing Home and Hospita · NA · not yet recruiting
- NCT07356336 — Cognitive Model for Behavioral Interventions as a Non-pharmacological Intervention for Behavioral and Psychological Symp · NA · recruiting
- NCT07212829 — The Added Value of Transcranial Direct Current Stimulation (tDCS) During Exercise for People With Chronic Widespread Pai · NA · not yet recruiting
- NCT07294131 — Targeting Muscle Strength Loss Due to Hospitalization in Older Adults by Blood-flow Restriction Combined With an Electro · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04721392 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vrije Universiteit Brussel
- Last refreshed: 22 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04721392.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing